Inflammatory conditions such as gout, type 2 diabetes, obesity, atherosclerosis, and Alzheimer’s disease exhibit aberrant Nlrp3 activation as a key contributor to disease pathogenesis [19,23,25,61]. This evidence concerns the gene NLRP3 and obesity due to melanocortin 4 receptor deficiency.